Concerning the experiments in cancer cells, the correlation between SIRT1 inhibition and the reported effects should be interpreted cautiously, since the doses employed (e.g., 50 μM or even more) in some studies may have also determined SIRT2 inhibition. The gene discussed is SIRT2; the disease is cancer.